Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 512

1.

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.

Rondaan C, Furer V, Heijstek MW, Agmon-Levin N, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, van Assen S, Elkayam O.

RMD Open. 2019 Sep 9;5(2):e001035. doi: 10.1136/rmdopen-2019-001035. eCollection 2019.

2.

Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern".

Smith V, Vanhaecke A, Herrick AL, Distler O, Guerra MG, Denton CP, Deschepper E, Foeldvari I, Gutierrez M, Hachulla E, Ingegnoli F, Kubo S, Müller-Ladner U, Riccieri V, Sulli A, van Laar JM, Vonk MC, Walker UA, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Autoimmun Rev. 2019 Sep 11:102394. doi: 10.1016/j.autrev.2019.102394. [Epub ahead of print] Review.

3.

The Adipokine Network in Rheumatic Joint Diseases.

Carrión M, Frommer KW, Pérez-García S, Müller-Ladner U, Gomariz RP, Neumann E.

Int J Mol Sci. 2019 Aug 22;20(17). pii: E4091. doi: 10.3390/ijms20174091. Review.

4.

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, de Thurah A, Landewé RB, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2019-215882. doi: 10.1136/annrheumdis-2019-215882. [Epub ahead of print]

PMID:
31413005
5.

An Unusual Cause of Hip Pain.

Lange U, Müller-Ladner U.

Dtsch Arztebl Int. 2019 Jun 10;116(23-24):412. doi: 10.3238/arztebl.2019.0412b. No abstract available.

6.

[Hand ischemia and increased CRP level in a 75-year-old female patient].

Decker E, Basten O, Librizzi D, Müller-Ladner U.

Z Rheumatol. 2019 Jun 13. doi: 10.1007/s00393-019-0655-2. [Epub ahead of print] German.

PMID:
31197459
7.

The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts.

Diller M, Frommer K, Dankbar B, Tarner I, Hülser ML, Tsiklauri L, Hasseli R, Sauerbier M, Pap T, Rehart S, Müller-Ladner U, Neumann E.

Arthritis Res Ther. 2019 Jun 10;21(1):144. doi: 10.1186/s13075-019-1926-7.

8.

Large variability of frequency and type of physical therapy in patients of the German Network for Systemic Sclerosis.

Belz D, Moinzadeh P, Riemekasten G, Henes J, Müller-Ladner U, Blank N, Koetter I, Siegert E, Pfeiffer C, Schmalzing M, Zeidler G, Schmeiser T, Worm M, Guenther C, Susok L, Kreuter A, Sunderkoetter C, Juche A, Aberer E, Gaebelein-Wissing N, Ramming A, Kuhr K, Hunzelmann N.

Arthritis Care Res (Hoboken). 2019 May 31. doi: 10.1002/acr.23998. [Epub ahead of print]

PMID:
31150152
9.

Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.

Blagojevic J, Abignano G, Avouac J, Cometi L, Frerix M, Bellando-Randone S, Guiducci S, Bruni C, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Czirják L, Denton CP, Distler O, Allanore Y, Müller-Ladner U, Moggi-Pignone A, Matucci-Cerinic M, Del Galdo F; EUSTAR co-workers.

Clin Rheumatol. 2019 May 20. doi: 10.1007/s10067-019-04564-8. [Epub ahead of print]

PMID:
31111363
10.

[41-Year Old Patient with Facial Swelling and Arthralgia].

Schulz N, Müller-Ladner U, Klemm P.

Dtsch Med Wochenschr. 2019 May;144(9):585-586. doi: 10.1055/a-0822-7584. Epub 2019 Apr 26. German. No abstract available.

PMID:
31026866
11.

A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity.

Karnell JL, Albulescu M, Drabic S, Wang L, Moate R, Baca M, Oganesyan V, Gunsior M, Thisted T, Yan L, Li J, Xiong X, Eck SC, de Los Reyes M, Yusuf I, Streicher K, Müller-Ladner U, Howe D, Ettinger R, Herbst R, Drappa J.

Sci Transl Med. 2019 Apr 24;11(489). pii: eaar6584. doi: 10.1126/scitranslmed.aar6584.

PMID:
31019027
12.

Capillaroscopic features of microangiopathy in rheumatoid arthritis patients with peripheral vascular syndrome.

Lambova SN, Müller-Ladner U.

Clin Rheumatol. 2019 Sep;38(9):2339-2341. doi: 10.1007/s10067-019-04561-x. Epub 2019 Apr 24. No abstract available.

PMID:
31016582
13.

Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib.

Diller M, Hasseli R, Hülser ML, Aykara I, Frommer K, Rehart S, Müller-Ladner U, Neumann E.

Front Immunol. 2019 Mar 26;10:541. doi: 10.3389/fimmu.2019.00541. eCollection 2019.

14.

Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.

Moinzadeh P, Kuhr K, Siegert E, Blank N, Sunderkoetter C, Henes J, Krusche M, Schmalzing M, Worm M, Schmeiser T, Günther C, Aberer E, Susok L, Riemekasten G, Kreuter A, Zeidler G, Juche A, Hadjiski D, Müller-Ladner U, Gaebelein-Wissing N, Distler JHW, Sárdy M, Krieg T, Hunzelmann N.

J Rheumatol. 2019 Apr 1. pii: jrheum.180582. doi: 10.3899/jrheum.180582. [Epub ahead of print]

PMID:
30936287
15.

Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.

Visvanathan S, Daniluk S, Ptaszyński R, Müller-Ladner U, Ramanujam M, Rosenstock B, Eleftheraki AG, Vinisko R, Petříková A, Kellner H, Dokoupilova E, Kwiatkowska B, Alten R, Schwabe C, Baum P, Joseph D, Fine JS, Padula SJ, Steffgen J.

Ann Rheum Dis. 2019 Jun;78(6):754-760. doi: 10.1136/annrheumdis-2018-214729. Epub 2019 Mar 22.

16.

Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie.

Wagner N, Assmus F, Arendt G, Baum E, Baumann U, Bogdan C, Burchard G, Föll D, Garbe E, Hecht J, Müller-Ladner U, Niehues T, Überla K, Vygen-Bonnet S, Weinke T, Wiese-Posselt M, Wojcinski M, Zepp F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):494-515. doi: 10.1007/s00103-019-02905-1. German. No abstract available.

PMID:
30899964
17.

Effectiveness and safety of anti-tumour necrosis factor therapy with certolizumab pegol observed in real-life rheumatoid arthritis patients in Germany: results from the non-interventional FαsT study.

Burmester G, Nüsslein H, von Hinüber U, Detert J, Richter C, Kumke T, Leunikava I, Lendl U, Fricke D, Müller-Ladner U.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):842-851. Epub 2019 Mar 7.

PMID:
30873942
18.

Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement.

Neumann E, Lepper N, Vasile M, Riccieri V, Peters M, Meier F, Hülser ML, Distler O, Gay S, Mahavadi P, Günther A, Roeb E, Frommer KW, Diller M, Müller-Ladner U.

Cytokine. 2019 May;117:41-49. doi: 10.1016/j.cyto.2018.11.013. Epub 2019 Feb 19.

PMID:
30784899
19.

Reply to 'Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature'.

Wegner F, Müller-Ladner U, Meier FM.

J Clin Neurosci. 2019 May;63:281. doi: 10.1016/j.jocn.2019.01.043. Epub 2019 Feb 4. No abstract available.

PMID:
30732990
20.

[Multimodal rheumatologic complex treatment of rheumatoid arthritis-a monocentric retrospective analysis].

Klemm P, Hudowenz O, Asendorf T, Müller-Ladner U, Lange U, Tarner IH.

Z Rheumatol. 2019 Mar;78(2):136-142. doi: 10.1007/s00393-019-0593-z. German.

PMID:
30715601
21.

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey.

Blagojevic J, Bellando-Randone S, Abignano G, Avouac J, Cometi L, Czirják L, Denton CP, Distler O, Frerix M, Guiducci S, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Allanore Y, Müller-Ladner U, Del Galdo F, Matucci-Cerinic M; EUSTAR co-workers.

Arthritis Res Ther. 2019 Jan 24;21(1):35. doi: 10.1186/s13075-019-1822-1.

22.

[Effects of serial mud baths on inflammatory rheumatic and degenerative diseases].

Dischereit G, Goronzy JE, Müller-Ladner U, Fetaj S, Lange U.

Z Rheumatol. 2019 Mar;78(2):143-154. doi: 10.1007/s00393-018-0582-7. German.

PMID:
30627845
23.

The Role of Extracellular Nucleic Acids in Rheumatoid Arthritis.

Neumann E, Hasseli R, Lange U, Müller-Ladner U.

Curr Pharm Biotechnol. 2018;19(15):1182-1188. doi: 10.2174/1389201020666190102150216. Review.

PMID:
30605055
24.

Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups.

Najm A, Le Goff B, Orr C, Thurlings R, Cañete JD, Humby F, Alivernini S, Manzo A, Just SA, Romão VC, Krenn V, Müller-Ladner U, Addimanda O, Tas SW, Stoenoiu M, de Bellefon LM, Durez P, Strand V, Wechalekar MD, Fonseca JE, Lauwerys B, Fearon U, Veale DJ; EULAR Synovitis Study Group and OMERACT Synovial Tissue Special Interest Group.

Arthritis Res Ther. 2018 Dec 19;20(1):282. doi: 10.1186/s13075-018-1795-5.

25.

Evidence of an anti-inflammatory toll-like receptor 9 (TLR 9) pathway in adipocytes.

Thomalla M, Schmid A, Neumann E, Pfefferle PI, Müller-Ladner U, Schäffler A, Karrasch T.

J Endocrinol. 2019 Feb 1;240(2):325-343. doi: 10.1530/JOE-18-0326.

PMID:
30508414
26.

Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups.

Najm A, Le Goff B, Orr C, Thurlings R, Cañete JD, Humby F, Alivernini S, Manzo A, Just SA, Romão VC, Krenn V, Müller-Ladner U, Addimanda O, Tas SW, Stoenoiu M, Meric de Bellefon L, Durez P, Strand V, Wechalekar MD, Fonseca JE, Lauwerys B, Fearon U, Veale DJ; EULAR Synovitis Study Group and OMERACT Synovial Tissue Special Interest Group.

Arthritis Res Ther. 2018 Dec 3;20(1):265. doi: 10.1186/s13075-018-1762-1. Erratum in: Arthritis Res Ther. 2018 Dec 19;20(1):282.

27.

Mixed connective tissue disease: state of the art on clinical practice guidelines.

Chaigne B, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Beretta L, Doria A, Guffroy A, Guimarães V, Hachulla É, Krieg T, Launay D, Lepri G, Moinzadeh P, Müller-Ladner U, Rednic S, Rodrigues A, Tas SW, van Vollenhoven RF, Vieira A, Bombardieri S, Fonseca JE, Galetti I, Schneider M, Smith V, Cutolo M, Mosca M, Fischer-Betz R.

RMD Open. 2018 Oct 18;4(Suppl 1):e000783. doi: 10.1136/rmdopen-2018-000783. eCollection 2018.

28.

Rituximab in routine care of severe active rheumatoid arthritis : A prospective, non-interventional study in Germany.

Krause A, Aries PM, Berger S, Fiehn C, Kellner H, Lorenz HM, Meier L, Müller GA, Müller-Ladner U, Schwarting A, Tony HP, Peters MA, Wendler J.

Z Rheumatol. 2018 Oct 1. doi: 10.1007/s00393-018-0552-0. [Epub ahead of print]

PMID:
30276727
29.

Interactions between rheumatoid arthritis synovial fibroblast migration and endothelial cells.

Zimmermann-Geller B, Köppert S, Kesel N, Hasseli R, Ullrich S, Lefèvre S, Frommer K, Gehrke T, Schönburg M, Rehart S, Schumacher U, Müller-Ladner U, Neumann E.

Immunol Cell Biol. 2019 Feb;97(2):178-189. doi: 10.1111/imcb.12208. Epub 2018 Nov 2.

PMID:
30252968
30.

[In-label in rheumatology-what is actually allowed?]

Müller-Ladner U.

Z Rheumatol. 2018 Sep;77(7):557-558. doi: 10.1007/s00393-018-0491-9. German. No abstract available.

PMID:
30171403
31.

Osteoarthritis - Current Insights in Pathogenesis, Diagnosis and Treatment.

Lambova SN, Müller-Ladner U.

Curr Rheumatol Rev. 2018;14(2):91-97. doi: 10.2174/157339711402180706144757. Review. No abstract available.

PMID:
30003854
32.

[Rheumatoid arthritis].

Neumann E, Frommer K, Diller M, Müller-Ladner U.

Z Rheumatol. 2018 Nov;77(9):769-775. doi: 10.1007/s00393-018-0500-z. Review. German.

PMID:
29974224
33.

[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs].

Fiehn C, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Krause A, Kuipers J, Lorenz HM, Müller-Ladner U, Nothacker M, Nüsslein H, Rubbert-Roth A, Schneider M, Schulze-Koops H, Seitz S, Sitter H, Specker C, Tony HP, Wassenberg S, Wollenhaupt J, Krüger K.

Z Rheumatol. 2018 Aug;77(Suppl 2):35-53. doi: 10.1007/s00393-018-0481-y. Review. German.

PMID:
29968101
34.

Visfatin alters the cytokine and matrix-degrading enzyme profile during osteogenic and adipogenic MSC differentiation.

Tsiklauri L, Werner J, Kampschulte M, Frommer KW, Berninger L, Irrgang M, Glenske K, Hose D, El Khassawna T, Pons-Kühnemann J, Rehart S, Wenisch S, Müller-Ladner U, Neumann E.

Osteoarthritis Cartilage. 2018 Sep;26(9):1225-1235. doi: 10.1016/j.joca.2018.06.001. Epub 2018 Jun 14.

35.

Dr. Wegner, et al, reply.

Wegner F, Müller-Ladner U, Meier FMP.

J Rheumatol. 2018 Jun;45(6):875. doi: 10.3899/jrheum.171439. No abstract available.

PMID:
29858457
36.

Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.

Jaeger VK, Valentini G, Hachulla E, Cozzi F, Distler O, Airó P, Czirják L, Allanore Y, Siegert E, Rosato E, Matucci-Cerinic M, Caimmi C, Henes J, Carreira PE, Smith V, Del Galdo F, Denton CP, Ullman S, De Langhe E, Riccieri V, Alegre-Sancho JJ, Rednic S, Müller-Ladner U, Walker UA; EUSTAR coauthors.

Arthritis Rheumatol. 2018 Nov;70(11):1829-1834. doi: 10.1002/art.40557. Epub 2018 Sep 24.

37.

[Rheumatological research networks in Germany].

Müller-Ladner U.

Z Rheumatol. 2018 May;77(Suppl 1):1-3. doi: 10.1007/s00393-018-0473-y. German. No abstract available.

PMID:
29728836
38.

[New insights into the function of bone marrow].

Schett G, Bozec A, Bekeredjian-Ding I, Chang HD, David JP, Dörner T, Grässel S, Gunzer M, Manz R, Mei H, Mielenz D, Müller-Ladner U, Neumann E, Radbruch A, Richter W, Straub RH.

Z Rheumatol. 2018 May;77(Suppl 1):4-7. doi: 10.1007/s00393-018-0456-z. Review. German. No abstract available.

PMID:
29691692
39.

German Pregnancy Register "Rhekiss".

Müller-Ladner U, Fischer-Betz R.

Dtsch Arztebl Int. 2018 Feb 16;115(7):112. doi: 10.3238/arztebl.2018.0112a. No abstract available.

40.

Editorial: Nailfold Capillaroscopy in Rheumatology.

Lambova SN, Muller-Ladner U.

Curr Rheumatol Rev. 2018 Apr 20;14(1):2-4. doi: 10.2174/1573397114666180215102621. No abstract available.

PMID:
29446745
41.

Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal.

Cutolo M, Melsens K, Wijnant S, Ingegnoli F, Thevissen K, De Keyser F, Decuman S, Müller-Ladner U, Piette Y, Riccieri V, Ughi N, Vandecasteele E, Vanhaecke A, Smith V.

Autoimmun Rev. 2018 Apr;17(4):344-352. doi: 10.1016/j.autrev.2017.11.025. Epub 2018 Feb 8. Review.

PMID:
29427827
42.

[Off to on: treatment of systemic immunological diseases with biologics].

Müller-Ladner U.

Z Rheumatol. 2018 Feb;77(1):10-11. doi: 10.1007/s00393-017-0406-1. German. No abstract available.

PMID:
29404761
43.

Mosaic capillaroscopic findings in systemic sclerosis.

Lambova SN, Müller-Ladner U.

Wien Med Wochenschr. 2018 Jun;168(9-10):248-249. doi: 10.1007/s10354-018-0617-3. Epub 2018 Feb 1.

PMID:
29392502
44.

[Revised version of the statement by the DGRh on biosimilars-update 2017].

Braun J, Lorenz HM, Müller-Ladner U, Schneider M, Schulze-Koops H, Specker C, Strangfeld A, Wagner U, Dörner T.

Z Rheumatol. 2018 Feb;77(1):81-90. doi: 10.1007/s00393-017-0407-0. German.

PMID:
29383440
45.

Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases.

Cutolo M, Melsens K, Herrick AL, Foeldvari I, Deschepper E, De Keyser F, Distler O, Ingegnoli F, Mostmans Y, Müller-Ladner U, Pizzorni C, Riccieri V, Ruaro B, Sulli A, Trombetta AC, Vanhaecke A, Smith V; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Rheumatology (Oxford). 2018 Apr 1;57(4):757-759. doi: 10.1093/rheumatology/kex460. Review. No abstract available.

46.

Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.

Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov NS, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman SM, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2018 Apr;77(4):563-570. doi: 10.1136/annrheumdis-2017-211912. Epub 2018 Jan 6.

47.

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.

Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, Pan X, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuta C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, Inanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Herrick AL.

Rheumatology (Oxford). 2018 Feb 1;57(2):370-381. doi: 10.1093/rheumatology/kex410.

48.

[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].

Schirmer JH, Aries PM, de Groot K, Hellmich B, Holle JU, Kneitz C, Kötter I, Lamprecht P, Müller-Ladner U, Reinhold-Keller E, Specker C, Zänker M, Moosig F.

Z Rheumatol. 2017 Nov;76(Suppl 3):77-104. doi: 10.1007/s00393-017-0394-1. Review. German. No abstract available.

PMID:
29204681
49.

Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis.

Arnold MB, Khanna D, Denton CP, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Riemekasten G, Steen V, Müller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE, Pope JE.

Rheumatology (Oxford). 2018 Jan 1;57(1):152-157. doi: 10.1093/rheumatology/kex396.

50.

Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).

Khanna D, Denton CP, Lin CJF, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Pope JE, Riemekasten G, Steen V, Müller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE.

Ann Rheum Dis. 2018 Feb;77(2):212-220. doi: 10.1136/annrheumdis-2017-211682. Epub 2017 Oct 24.

Supplemental Content

Loading ...
Support Center